Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11176
PUT
Paysafe
PSFE
$375M
| $163K | ﹤0.01% |
20,200
-28,500
| -59% | -$276K |
|
11177
TScan Therapeutics
TCRX
$52M
| $163K | ﹤0.01% |
162,877
-227,870
| -58% | -$330K |
|
|
KREF
11178
PUT
KKR Real Estate Finance Trust
KREF
$499M
| $163K | ﹤0.01% |
19,800
+9,700
| +96% | +$82.1K |
|
|
SLAI
11179
DELISTED
SOLAI Ltd ADS
SLAI
| $163K | ﹤0.01% |
+34,642
| New | +$447K |
|
11180
Riverview Bancorp
RVSB
$108M
| $163K | ﹤0.01% |
32,374
-25,410
| -44% | -$133K |
|
|
NYXH
11181
Nyxoah
NYXH
$147M
| $162K | ﹤0.01% |
35,324
+14,104
| +66% | +$72.6K |
|
11182
PUT
FIGS
FIGS
$2.38B
| $162K | ﹤0.01% |
+14,300
| New | +$134K |
|
11183
Hennessy Advisors
HNNA
$78.5M
| $162K | ﹤0.01% |
16,891
-3,772
| -18% | -$37.3K |
|
11184
PUT
Unisys
UIS
$217M
| $162K | ﹤0.01% |
58,700
-50,200
| -46% | -$157K |
|
|
SACH
11185
Sachem Capital Corp
SACH
$39.8M
| $162K | ﹤0.01% |
155,624
+144,161
| +1,258% | +$154K |
|
11186
PUT
MiMedx Group
MDXG
$633M
| $162K | ﹤0.01% |
23,900
-33,800
| -59% | -$237K |
|
11187
PUT
Chegg
CHGG
$103M
| $162K | ﹤0.01% |
173,700
+7,800
| +5% | +$8.5K |
|
|
CEPO
11188
PUT
Cantor Equity Partners I
CEPO
$272M
| $162K | ﹤0.01% |
15,500
+4,600
| +42% | +$48.1K |
|
11189
CALL
Evolent Health
EVH
$444M
| $161K | ﹤0.01% |
40,300
+4,300
| +12% | +$23.9K |
|
11190
PUT
Yext
YEXT
$574M
| $161K | ﹤0.01% |
20,000
+3,400
| +20% | +$28.6K |
|
11191
CALL
Spok Holdings
SPOK
$241M
| $161K | ﹤0.01% |
+12,200
| New | +$173K |
|
|
CCIF
11192
Carlyle Credit Income Fund
CCIF
$60.2M
| $161K | ﹤0.01% |
34,300
+19,087
| +125% | +$97.7K |
|
|
VHCPU
11193
Vine Hill Capital Investment Corp II Units
VHCPU
$176M
| $161K | ﹤0.01% |
+16,050
| New | +$161K |
|
11194
PUT
Intellicheck
IDN
$79.6M
| $160K | ﹤0.01% |
24,000
-14,300
| -37% | -$80.7K |
|
11195
CALL
GraniteShares 2x Short TSLA Daily ETF
TSDD
$29.3M
| $160K | ﹤0.01% |
20,700
+2,200
| +12% | +$20.4K |
|
11196
CALL
Cars.com
CARS
$689M
| $160K | ﹤0.01% |
+13,100
| New | +$152K |
|
|
BMNU
11197
T-REX 2X Long BMNR Daily Target ETF
BMNU
$262M
| $160K | ﹤0.01% |
+3,339
| New | +$510K |
|
11198
CALL
Riskified
RSKD
$716M
| $160K | ﹤0.01% |
+32,100
| New | +$155K |
|
|
GPAT
11199
GP-Act III Acquisition Corp
GPAT
$401M
| $160K | ﹤0.01% |
14,909
-3,857
| -21% | -$41.1K |
|
|
BTX
11200
BlackRock Technology and Private Equity Term Trust
BTX
$1B
| $159K | ﹤0.01% |
+24,172
| New | +$163K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.